ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer-Reference-Cited by-同舟云学术

ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

Published:2022-09 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Devos Gaëtan,Tosco Lorenzo,Baldewijns Marcella,Gevaert Thomas,Goffin Karolien,Petit Valentin,Mai Cindy,Laenen Annouschka,Raskin Yannic,Van Haute Carl,Goeman Lieven,De Meerleer Gert,Berghen Charlien,Devlies Wout,Claessens Frank,Van Poppel Hendrik,Everaerts Wouter,Joniau Steven

Publisher

Elsevier BV

Subject

Urology

Reference34 articles.

1. Changing nature of high risk patients undergoing radical prostatectomy;Kane;J Urol,2007

2. Prostate cancer-specific mortality burden by risk group among men with localized disease: implications for research and clinical trial priorities;Dee;Prostate,2020

3. Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer;Bianco;Prostate,2001

4. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival;Wood;J Clin Oncol,1997

5. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment;Köllermann;J Clin Oncol,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

2. Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-13

3. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07

4. Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer;European Urology;2024-08

5. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05